Novelix Pharmaceuticals Ltd

📈 Mallela Venkataramna Reddy Increases Stake in Novelix Pharmaceuticals to 9.18%

• Acquired 330,000 equity shares via preferential allotment on February 12, 2026

• Represents 1.66% of total share capital and 1.21% of diluted voting capital

• Total holding now stands at 1,830,000 shares (9.18% of voting rights, 6.71% diluted)

• Classified as non-promoter shareholder

• Company's equity share capital increased from ₹176,150,000 to ₹199,350,000

• Total diluted share capital including convertible warrants is ₹266,850,000